Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
60.7M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
27.1M
-
Shares change
-
+1.5M
-
Total reported value, excl. options
-
$106M
-
Value change
-
-$3.03M
-
Number of buys
-
38
-
Number of sells
-
-17
-
Price
-
$3.91
Significant Holders of Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) as of Q1 2022
64 filings reported holding ABOS - Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q1 2022.
Acumen Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (ABOS) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.1M shares
of 60.7M outstanding shares and own 44.61% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.77M shares), BlackRock Inc. (3.83M shares), Sands Capital Ventures, LLC (3.42M shares), Deep Track Capital, LP (2.6M shares), VANGUARD GROUP INC (1.23M shares), GREAT POINT PARTNERS LLC (928K shares), Laurion Capital Management LP (657K shares), PERCEPTIVE ADVISORS LLC (597K shares), Woodline Partners LP (501K shares), and GUARDIAN POINT CAPITAL, LP (500K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.